Neutralization of small RNA viruses by antibodies and antiviral agents 1

The 3‐dimensional structures of a number of small animal RNA viruses are now known to near‐atomic resolution. All these viruses have similar structures and have, in all probability, diverged from a common ancestral virus able to infect a variety of organisms. The structures have elucidated the site of attachment to host cell receptors and the mode of protection of this site against host immune pressure. An internal hydrophobic pocket in rhinoviruses is the site for binding of antiviral drugs that inhibit uncoating and can inhibit attachment in some viruses. The pocket is probably a functional necessity, and thus is a suitable target for well‐designed antiviral agents in many viruses.— Rossmann, M. G. Neutralization of small RNA viruses by antibodies and antiviral agents. FASEB J. 3: 2335‐2343; 1989.

[1]  Y. Li,et al.  Protein-RNA interactions in an icosahedral virus at 3.0 A resolution. , 1989, Science.

[2]  A. Treasurywala,et al.  Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors , 1989, Journal of virology.

[3]  David Rowlands,et al.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution , 1989, Nature.

[4]  C. Wychowski,et al.  Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. , 1988, The EMBO journal.

[5]  M. Murcko,et al.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Wimmer,et al.  Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. , 1988, Science.

[7]  M. Rossmann.  Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[9]  M. Rossmann,et al.  Conservation of the putative receptor attachment site in picornaviruses. , 1988, Virology.

[10]  M G Rossmann,et al.  Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Rossmann.  The evolution of RNA viruses , 1987, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  G. Allaway,et al.  Analysis of the bond between encephalomyocarditis virus and its human erythrocyte receptor by affinity chromatography on virus-sepharose columns. , 1987, The Journal of general virology.

[13]  G. Vriend,et al.  The atomic structure of Mengo virus at 3.0 A resolution. , 1987, Science.

[14]  M. Mckinlay,et al.  Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice. , 1986, The Journal of infectious diseases.

[15]  G. Allaway,et al.  Site of attachment of encephalomyocarditis virus on human erythrocytes , 1986, Journal of virology.

[16]  M. Otto,et al.  Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug , 1986, Antimicrobial Agents and Chemotherapy.

[17]  J. Tomassini,et al.  Isolation of a receptor protein involved in attachment of human rhinoviruses , 1986, Journal of virology.

[18]  M. Mckinlay,et al.  [[(4,5‐Dihydro‐2‐oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of Picornavirus Uncoating. , 1986 .

[19]  J. Icenogle,et al.  Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. , 1986, The Journal of general virology.

[20]  N. La Monica,et al.  Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing , 1986, Journal of virology.

[21]  M. Mckinlay,et al.  Oral efficacy of WIN 51711 in mice infected with human poliovirus , 1986, Antimicrobial Agents and Chemotherapy.

[22]  B. Sherry,et al.  Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14 , 1986, Journal of virology.

[23]  R. Colonno,et al.  Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses , 1986, Journal of virology.

[24]  D. Filman,et al.  Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.

[25]  John E. Johnson,et al.  Structure of a human common cold virus and functional relationship to other picornaviruses , 1985, Nature.

[26]  J. Mapoles,et al.  Purification of a HeLa cell receptor protein for group B coxsackieviruses , 1985, Journal of virology.

[27]  M. Otto,et al.  In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug , 1985, Antimicrobial Agents and Chemotherapy.

[28]  M. Luo,et al.  Virion orientation in cubic crystals of the human common cold virus HRV14. , 1984, Journal of molecular biology.

[29]  H. Ishitsuka,et al.  Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation. , 1984, Virology.

[30]  E. Wimmer,et al.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides , 1983, Nature.

[31]  R. Rueckert,et al.  Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. , 1983, Virology.

[32]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[33]  T. A. Jones,et al.  Structure of satellite tobacco necrosis virus at 3.0 A resolution. , 1982, Journal of molecular biology.

[34]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[35]  I. Wilson,et al.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation , 1981, Nature.

[36]  L. Caliguiri,et al.  Effect of arildone on modifications of poliovirus in vitro. , 1980, Virology.

[37]  John E. Johnson,et al.  Structure of southern bean mosaic virus at 2.8 Å resolution , 1980, Nature.

[38]  H. Eggers,et al.  Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. , 1979, Virology.

[39]  S. Harrison,et al.  Tomato bushy stunt virus at 2.9 Å resolution , 1978, Nature.

[40]  Robert E. Johnson,et al.  Antiviral activity of some .beta.-diketones. 2. Aryloxy alkyl diketones. In vitro activity against both RNA and DNA viruses , 1977 .

[41]  K. Lonberg-Holm.  The effects of concanavalin A on the early events of infection by rhinovirus type 2 and poliovirus type 2. , 1975, The Journal of general virology.

[42]  K. Lonberg-Holm,et al.  Early alteration of poliovirus in infected cells and its specific inhibition. , 1975, The Journal of general virology.

[43]  M. Rossmann,et al.  Inhibitors of viral uncoating. , 1989, Pharmacology & therapeutics.

[44]  John E. Johnson,et al.  Structure of an insect virus at 3.0 Å resolution , 1987, Proteins.

[45]  J. Richardson,et al.  The anatomy and taxonomy of protein structure. , 1981, Advances in protein chemistry.

[46]  A. Klug,et al.  Physical principles in the construction of regular viruses. , 1962, Cold Spring Harbor symposia on quantitative biology.